The Gynecologic Oncology Group study is sponsored
by vaccine developers, Advaxis, Inc., a Princeton, New Jersey - based company that focuses on immunotherapies to combat cancer.
This reinforces the European leadership in controlling the burden and spread of diseases, and the economic assets represented
by vaccine developers in Europe.
Not exact matches
The so - called «human challenge model» has a long and checkered past that began with 18th century experiments
by smallpox
vaccine developer Edward Jenner and later fell under intense scrutiny when they were conducted
by Nazi doctors, military researchers, and academic scientists working with prisoners.
Even so, the complex
vaccine will be expensive
by developing world standards, and its cost - effectiveness is a major issue for
vaccine developers and public health experts, says Scott Filler of the Global Fund to Fight AIDS, Tuberculosis and Malaria.